Krilogy Financial LLC Takes Position in The Sherwin-Williams Company $SHW

Krilogy Financial LLC bought a new position in The Sherwin-Williams Company (NYSE:SHWFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,768 shares of the specialty chemicals company’s stock, valued at approximately $594,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Brighton Jones LLC boosted its holdings in Sherwin-Williams by 73.6% during the fourth quarter. Brighton Jones LLC now owns 1,545 shares of the specialty chemicals company’s stock valued at $525,000 after purchasing an additional 655 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Sherwin-Williams by 11.2% in the 1st quarter. Empowered Funds LLC now owns 6,236 shares of the specialty chemicals company’s stock valued at $2,178,000 after purchasing an additional 626 shares during the period. CWM LLC boosted its position in shares of Sherwin-Williams by 23.9% in the 2nd quarter. CWM LLC now owns 10,063 shares of the specialty chemicals company’s stock worth $3,455,000 after purchasing an additional 1,940 shares during the last quarter. Mutual Advisors LLC grew its stake in shares of Sherwin-Williams by 12.4% during the second quarter. Mutual Advisors LLC now owns 873 shares of the specialty chemicals company’s stock worth $297,000 after purchasing an additional 96 shares during the period. Finally, Nordea Investment Management AB lifted its stake in Sherwin-Williams by 50.1% in the second quarter. Nordea Investment Management AB now owns 108,492 shares of the specialty chemicals company’s stock valued at $37,203,000 after buying an additional 36,200 shares during the period. Institutional investors own 77.67% of the company’s stock.

Sherwin-Williams Trading Down 1.0%

SHW opened at $368.74 on Friday. The stock has a market capitalization of $91.41 billion, a P/E ratio of 35.90, a P/E/G ratio of 3.19 and a beta of 1.25. The company has a current ratio of 0.87, a quick ratio of 0.53 and a debt-to-equity ratio of 2.03. The Sherwin-Williams Company has a 12 month low of $308.84 and a 12 month high of $379.65. The firm’s fifty day simple moving average is $342.99 and its 200 day simple moving average is $345.54.

Sherwin-Williams (NYSE:SHWGet Free Report) last released its quarterly earnings results on Thursday, January 29th. The specialty chemicals company reported $2.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.16 by $0.07. The firm had revenue of $5.60 billion for the quarter, compared to the consensus estimate of $5.57 billion. Sherwin-Williams had a return on equity of 65.26% and a net margin of 10.90%.The company’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter last year, the business posted $2.09 EPS. As a group, research analysts anticipate that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Colin M. Davie sold 2,976 shares of the firm’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $359.50, for a total transaction of $1,069,872.00. Following the completion of the transaction, the insider directly owned 5,365 shares of the company’s stock, valued at $1,928,717.50. This trade represents a 35.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Royal Bank Of Canada set a $390.00 price target on Sherwin-Williams and gave the company an “outperform” rating in a research note on Friday, January 30th. Wells Fargo & Company set a $410.00 target price on shares of Sherwin-Williams and gave the stock an “overweight” rating in a report on Wednesday, October 29th. UBS Group set a $420.00 price target on shares of Sherwin-Williams in a research report on Friday, January 30th. Citigroup restated a “buy” rating on shares of Sherwin-Williams in a research report on Monday, January 19th. Finally, JPMorgan Chase & Co. lifted their target price on Sherwin-Williams from $378.00 to $385.00 and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Eleven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $386.33.

View Our Latest Stock Report on Sherwin-Williams

Sherwin-Williams Company Profile

(Free Report)

Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.

The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.

Featured Articles

Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHWFree Report).

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.